IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v5y2021i3d10.1007_s41669-020-00252-5.html
   My bibliography  Save this article

Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)

Author

Listed:
  • Meryl Brod

    (The Brod Group)

  • Michael Højby Rasmussen

    (Novo Nordisk A/S)

  • Knud Vad

    (Novo Nordisk A/S)

  • Suzanne Alolga

    (The Brod Group)

  • Donald M. Bushnell

    (Health Research Associates, Inc)

  • Jacques Bedoin

    (Novo Nordisk A/S)

  • Aristides Maniatis

    (Rocky Mountain Pediatric Endocrinology)

Abstract

Objective The aim of this study was to perform psychometric testing of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM): a patient-reported outcome (PRO) for children with GHD aged 9 to 0.70), as was test–retest reliability for the SWB, EWB and overall (above 0.70). At least one convergent validity hypotheses for each domain and overall was proven (r > 0.40). Known-groups validity hypotheses for the EWB and SWB domains were significant (p

Suggested Citation

  • Meryl Brod & Michael Højby Rasmussen & Knud Vad & Suzanne Alolga & Donald M. Bushnell & Jacques Bedoin & Aristides Maniatis, 2021. "Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)," PharmacoEconomics - Open, Springer, vol. 5(3), pages 505-518, September.
    • Handle: RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-020-00252-5
    DOI: 10.1007/s41669-020-00252-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-020-00252-5
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1007/s41669-020-00252-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-020-00252-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.